Literature DB >> 1946576

The effect of theophylline on essential tremor: the possible role of GABA.

J Mally1, T W Stone.   

Abstract

The chronic administration of theophylline was studied in twenty patients with essential tremor in a double-blind cross-over trial. The tremor was improved significantly after four weeks of treatment. In mice the chronic administration of theophylline was compared with propranolol on the modulation by adenosine, 5-HT, (-)isoprenaline or GABA of NMDA-induced depolarisation of neocortical slices. Adenosine depolarisation was abolished by two-weeks treatment with theophylline but not propranolol. Potentiation by (-)isoprenaline of NMDA responses was reduced by theophylline (100 mg/kg/day) and propranolol treatment (25 mg/kg/day), but a lower dose of propranolol further increased it. The enhancement by 5-HT of NMDA-induced depolarisation was unaffected by the pretreatment with theophylline, while the higher dose of propranolol blocked it. GABA caused no significant change of NMDA depolarisation in control slices, but after theophylline treatment (100 mg/kg/day) and propranolol administration at both doses it significantly potentiated NMDA depolarisation. The enhancement of GABA sensitivity might be an important common factor in decreasing the essential tremor after propranolol and theophylline treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1946576     DOI: 10.1016/0091-3057(91)90190-d

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Change in the concentrations of amino acids in CSF and serum of patients with essential tremor.

Authors:  J Málly; M Baranyi; E S Vizi
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Change in the concentrations of amino acids in cisternal CSF of patients with essential tremor.

Authors:  J Málly; M Baranyi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

3.  Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor.

Authors:  Elena García-Martín; Carmen Martínez; Hortensia Alonso-Navarro; Julián Benito-León; Oswaldo Lorenzo-Betancor; Pau Pastor; Inmaculada Puertas; Lluisa Rubio; Tomás López-Alburquerque; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  J Neurol       Date:  2010-09-05       Impact factor: 4.849

Review 4.  Linking Essential Tremor to the Cerebellum: Neurochemical Evidence.

Authors:  Juan Marin-Lahoz; Alexandre Gironell
Journal:  Cerebellum       Date:  2016-06       Impact factor: 3.847

5.  Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study.

Authors:  Davide Uccellini; G Grampa; I La Spina; D Nasuelli; I Neromante; L Politini; F Reverberi; D Porazzi; V Carli; G Camardese
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

6.  Overview of essential tremor.

Authors:  Theresa A Zesiewicz; Abinaya Chari; Israt Jahan; Amber M Miller; Kelly L Sullivan
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

7.  GABA-gated chloride ion influx in brains of tremor rats.

Authors:  K Kishi; M Ito; A Tsuda; H Tsuda; H Shiraishi; H Sejima; C Mori; T Serikawa; J Yamada
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

8.  Neuroimaging of Essential Tremor: What is the Evidence for Cerebellar Involvement?

Authors:  Luca Passamonti; Antonio Cerasa; Aldo Quattrone
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-09-17

9.  Essential tremor: treatment options.

Authors:  William G Ondo
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.972

10.  The GABA Hypothesis in Essential Tremor: Lights and Shadows.

Authors:  Alexandre Gironell
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.